Aspergillus broncho pulmonary aspergillosis ABPA Test in Varanasi

Aspergillus species are ubiquitous environmental molds that grow on organic matter. Aspergillus molds continuously disseminate spores (conidia) into the environment. Allergic Bronchopulmonary Aspergillosis (ABPA) is an allergic reaction to Aspergilli that almost exclusively affects individuals with asthma or cystic fibrosis. It develops when the airways of patients with asthma or cystic fibrosis become colonized with species of Aspergillus.

ABPA typically causes bronchospasm and mucus build-up resulting in coughing, breathing difficulty and airway obstruction. Bronchiectasis can develop, resulting in worsening lung function and increased risk of infection. ABPA in patients with poorly controlled asthma has also been referred to as Severe Asthma with Fungal Sensitization (SAFS).

Treatment is with corticosteroids and, in patients with refractory disease, itraconazole.

Associated Tests: 

Allergy - Adult (Comprehensive) Panel 

Allergy Screening 

Written by: Supriya Kulkarni, Lead-Content & Training

Reviewed by : Dr. Alap Christry M.D. AVP-Lab Operations & Scientific Business Head-Clinical Chemistry